Corvus Pharmaceuticals Inc CRVS

NAS: CRVS | ISIN: US2210151005 14/11/2024

8,520 USD (-3,95%)

(-3,95%) 14/11/2024

Grafiek Corvus Pharmaceuticals Inc

Grafiek Corvus Pharmaceuticals Inc

1 dag1d -3,95%
1 week1w -9,84%
1 maand1m 26,79%
3 maanden3m 124,21%
6 maanden6m 283,78%
1 jaar1j 464,24%
5 jaar5j 194,81%

Corvus Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

26 oktober 2021 · Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 · Persbericht

5 maart 2021 · Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences · Persbericht

17 februari 2021 · Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock · Persbericht

12 februari 2021 · Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock · Persbericht

11 februari 2021 · Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock · Persbericht

4 februari 2021 · Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19 · Persbericht

Profiel Corvus Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.corvuspharma.com

Hoofdzetel: Burlingame, California Verenigde Staten

CEO: Richard Miller

Werknemers: 36

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe